Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
amitriptyline — M1 receptor Interaction
Drug-target interaction between amitriptyline and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — M2 receptor Interaction
Drug-target interaction between amitriptyline and M2 receptor. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — M3 receptor Interaction
Drug-target interaction between amitriptyline and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — M4 receptor Interaction
Drug-target interaction between amitriptyline and M4 receptor. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — M5 receptor Interaction
Drug-target interaction between amitriptyline and M5 receptor. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — NET Interaction
Drug-target interaction between amitriptyline and NET. Synthetic organic pharmacological agent targeting this protein.
amitriptyline — SERT Interaction
Drug-target interaction between amitriptyline and SERT. Synthetic organic pharmacological agent targeting this protein.
amivantamab — epidermal growth factor receptor Interaction
Drug-target interaction between amivantamab and epidermal growth factor receptor. Antibody pharmacological agent targeting this protein.
amivantamab — MET proto-oncogene, receptor tyrosine kinase Interaction
Drug-target interaction between amivantamab and MET proto-oncogene, receptor tyrosine kinase. Antibody pharmacological agent targeting this protein.
amoxapine — NET Interaction
Drug-target interaction between amoxapine and NET. Synthetic organic pharmacological agent targeting this protein.
amoxapine — SERT Interaction
Drug-target interaction between amoxapine and SERT. Synthetic organic pharmacological agent targeting this protein.
anagrelide — phosphodiesterase 3A Interaction
Drug-target interaction between anagrelide and phosphodiesterase 3A. Synthetic organic pharmacological agent targeting this protein.
anakinra — Interleukin-1 receptor, type I Interaction
Drug-target interaction between anakinra and Interleukin-1 receptor, type I. Peptide pharmacological agent targeting this protein.
anastrozole — CYP19A1 Interaction
Drug-target interaction between anastrozole and CYP19A1. Synthetic organic pharmacological agent targeting this protein.
anifrolumab — interferon α/β receptor 1 Interaction
Drug-target interaction between anifrolumab and interferon α/β receptor 1. Antibody pharmacological agent targeting this protein.
anisindione — γ-Glutamyl carboxylase Interaction
Drug-target interaction between anisindione and γ-Glutamyl carboxylase. Synthetic organic pharmacological agent targeting this protein.
anrikefon — κ receptor Interaction
Drug-target interaction between anrikefon and κ receptor. Peptide pharmacological agent targeting this protein.
apalutamide — Androgen receptor Interaction
Drug-target interaction between apalutamide and Androgen receptor. Synthetic organic pharmacological agent targeting this protein.
apixaban — coagulation factor X Interaction
Drug-target interaction between apixaban and coagulation factor X. Synthetic organic pharmacological agent targeting this protein.
apomorphine — D2 receptor Interaction
Drug-target interaction between apomorphine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
apomorphine — D3 receptor Interaction
Drug-target interaction between apomorphine and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
apomorphine — D4 receptor Interaction
Drug-target interaction between apomorphine and D4 receptor. Synthetic organic pharmacological agent targeting this protein.
apraclonidine — α2A-adrenoceptor Interaction
Drug-target interaction between apraclonidine and α2A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
apraclonidine — α2C-adrenoceptor Interaction
Drug-target interaction between apraclonidine and α2C-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
apremilast — phosphodiesterase 4A Interaction
Drug-target interaction between apremilast and phosphodiesterase 4A. Synthetic organic pharmacological agent targeting this protein.
apremilast — phosphodiesterase 4B Interaction
Drug-target interaction between apremilast and phosphodiesterase 4B. Synthetic organic pharmacological agent targeting this protein.
apremilast — phosphodiesterase 4C Interaction
Drug-target interaction between apremilast and phosphodiesterase 4C. Synthetic organic pharmacological agent targeting this protein.
apremilast — phosphodiesterase 4D Interaction
Drug-target interaction between apremilast and phosphodiesterase 4D. Synthetic organic pharmacological agent targeting this protein.
aprepitant — NK1 receptor Interaction
Drug-target interaction between aprepitant and NK1 receptor. Synthetic organic pharmacological agent targeting this protein.
aprotinin — plasminogen Interaction
Drug-target interaction between aprotinin and plasminogen. Peptide pharmacological agent targeting this protein.
argatroban — coagulation factor II, thrombin Interaction
Drug-target interaction between argatroban and coagulation factor II, thrombin. Synthetic organic pharmacological agent targeting this protein.
aripiprazole — D2 receptor Interaction
Drug-target interaction between aripiprazole and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
asenapine — 5-HT2A receptor Interaction
Drug-target interaction between asenapine and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
asenapine — D2 receptor Interaction
Drug-target interaction between asenapine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
aspirin — COX-1 Interaction
Drug-target interaction between aspirin and COX-1. Synthetic organic pharmacological agent targeting this protein.
aspirin — COX-2 Interaction
Drug-target interaction between aspirin and COX-2. Synthetic organic pharmacological agent targeting this protein.
astemizole — H1 receptor Interaction
Drug-target interaction between astemizole and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
atenolol — β1-adrenoceptor Interaction
Drug-target interaction between atenolol and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
atomoxetine — NET Interaction
Drug-target interaction between atomoxetine and NET. Synthetic organic pharmacological agent targeting this protein.
atorvastatin — hydroxymethylglutaryl-CoA reductase Interaction
Drug-target interaction between atorvastatin and hydroxymethylglutaryl-CoA reductase. Synthetic organic pharmacological agent targeting this protein.
atrasentan — ETA receptor Interaction
Drug-target interaction between atrasentan and ETA receptor. Synthetic organic pharmacological agent targeting this protein.
atropine — M1 receptor Interaction
Drug-target interaction between atropine and M1 receptor. Natural product pharmacological agent targeting this protein.
atropine — M2 receptor Interaction
Drug-target interaction between atropine and M2 receptor. Natural product pharmacological agent targeting this protein.
atropine — M3 receptor Interaction
Drug-target interaction between atropine and M3 receptor. Natural product pharmacological agent targeting this protein.
atropine — M4 receptor Interaction
Drug-target interaction between atropine and M4 receptor. Natural product pharmacological agent targeting this protein.
atropine — M5 receptor Interaction
Drug-target interaction between atropine and M5 receptor. Natural product pharmacological agent targeting this protein.
axitinib — kinase insert domain receptor Interaction
Drug-target interaction between axitinib and kinase insert domain receptor. Synthetic organic pharmacological agent targeting this protein.
azelastine — H1 receptor Interaction
Drug-target interaction between azelastine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
baclofen — GABAB receptor Interaction
Drug-target interaction between baclofen and GABAB receptor. Synthetic organic pharmacological agent targeting this protein.
baricitinib — Janus kinase 1 Interaction
Drug-target interaction between baricitinib and Janus kinase 1. Synthetic organic pharmacological agent targeting this protein.
baricitinib — Janus kinase 2 Interaction
Drug-target interaction between baricitinib and Janus kinase 2. Synthetic organic pharmacological agent targeting this protein.
bazedoxifene — Estrogen receptor-α Interaction
Drug-target interaction between bazedoxifene and Estrogen receptor-α. Synthetic organic pharmacological agent targeting this protein.
bazedoxifene — Estrogen receptor-β Interaction
Drug-target interaction between bazedoxifene and Estrogen receptor-β. Synthetic organic pharmacological agent targeting this protein.
beclometasone — Glucocorticoid receptor Interaction
Drug-target interaction between beclometasone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
belatacept — CD80 Interaction
Drug-target interaction between belatacept and CD80. Peptide pharmacological agent targeting this protein.
belatacept — CD86 Interaction
Drug-target interaction between belatacept and CD86. Peptide pharmacological agent targeting this protein.
belumosudil — Rho associated coiled-coil containing protein kinase 1 Interaction
Drug-target interaction between belumosudil and Rho associated coiled-coil containing protein kinase 1. Synthetic organic pharmacological agent targeting this protein.
belumosudil — Rho associated coiled-coil containing protein kinase 2 Interaction
Drug-target interaction between belumosudil and Rho associated coiled-coil containing protein kinase 2. Synthetic organic pharmacological agent targeting this protein.
benazepril — Angiotensin-converting enzyme Interaction
Drug-target interaction between benazepril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
benazeprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between benazeprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.